Verrica Pharmaceuticals
VRCA
#9756
Rank
ยฃ64.74 M
Marketcap
ยฃ3.77
Share price
-7.72%
Change (1 day)
-23.37%
Change (1 year)

Revenue for Verrica Pharmaceuticals (VRCA)

Revenue in 2026 (TTM): ยฃ27.49 Million

According to Verrica Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is ยฃ27.89 Million. In 2025 the company made a revenue of ยฃ26.41 Million an increase over the revenue in the year 2024 that were of ยฃ6.02 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Verrica Pharmaceuticals from 2017 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) ยฃ27.49 M4.08%
2025 ยฃ26.41 M338.17%
2024 ยฃ6.02 M49.9%
2023 ยฃ4.02 M-46.13%
2022 ยฃ7.46 M-16.02%
2021 ยฃ8.88 M
2020 N/A
2019 N/A
2018 N/A
2017 N/A